share_log

藥明合聯：董事會會議通告

WUXI XDC: NOTICE OF BOARD MEETING

HKEX ·  Jul 29 17:04

Summary by Futu AI

藥明合聯生物技術有限公司宣佈，將於2024年8月20日舉行董事會會議，主要目的是審議及批准該集團截至2024年6月30日止六個月的中期業績及其發佈。該公司由執行董事兼首席執行官李錦才博士領導，董事會成員還包括其他執行董事、非執行董事以及獨立非執行董事。會議將在香港時間2024年7月29日召開。
藥明合聯生物技術有限公司宣佈，將於2024年8月20日舉行董事會會議，主要目的是審議及批准該集團截至2024年6月30日止六個月的中期業績及其發佈。該公司由執行董事兼首席執行官李錦才博士領導，董事會成員還包括其他執行董事、非執行董事以及獨立非執行董事。會議將在香港時間2024年7月29日召開。
WuXi Biologics Holdings Limited announced that it will hold a board of directors meeting on August 20, 2024, the main purpose of which is to review and approve the group's mid-year performance up to June 30, 2024 and its publication. The company is led by Dr. Li Jianguo, executive director and CEO, with other executive directors, non-executive directors, and independent non-executive directors on the board. The meeting will be held on July 29, 2024, Hong Kong time.
WuXi Biologics Holdings Limited announced that it will hold a board of directors meeting on August 20, 2024, the main purpose of which is to review and approve the group's mid-year performance up to June 30, 2024 and its publication. The company is led by Dr. Li Jianguo, executive director and CEO, with other executive directors, non-executive directors, and independent non-executive directors on the board. The meeting will be held on July 29, 2024, Hong Kong time.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated